Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Docetaxel in Advanced Urothelial Carcinoma
NCT00004223Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Feb 2000
- Primary completion
- Oct 2002
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of gemcitabine, docetaxel in urothelial carcinoma (UC), sponsored by Eastern Cooperative Oncology Group. Started Feb 2000; status: completed.
02
Drugs
gemcitabinedocetaxel
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00004223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004223.